CN102409110B - 一种人***瘤病毒型原位杂交检测试剂盒及其方法 - Google Patents
一种人***瘤病毒型原位杂交检测试剂盒及其方法 Download PDFInfo
- Publication number
- CN102409110B CN102409110B CN 201110415700 CN201110415700A CN102409110B CN 102409110 B CN102409110 B CN 102409110B CN 201110415700 CN201110415700 CN 201110415700 CN 201110415700 A CN201110415700 A CN 201110415700A CN 102409110 B CN102409110 B CN 102409110B
- Authority
- CN
- China
- Prior art keywords
- hybridization
- solution
- slide
- situ hybridization
- situ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 40
- 238000007901 in situ hybridization Methods 0.000 title claims abstract description 31
- 241000701806 Human papillomavirus Species 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title abstract description 33
- 239000000523 sample Substances 0.000 claims abstract description 75
- 238000009396 hybridization Methods 0.000 claims abstract description 54
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims description 39
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 27
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 12
- -1 methane amide Chemical class 0.000 claims description 11
- 229960005156 digoxin Drugs 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 10
- 238000011065 in-situ storage Methods 0.000 claims description 9
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 6
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 108010039918 Polylysine Proteins 0.000 claims description 6
- 235000014121 butter Nutrition 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 229920000656 polylysine Polymers 0.000 claims description 6
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 5
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 4
- 239000003593 chromogenic compound Substances 0.000 claims description 4
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 4
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 3
- 241000972773 Aulopiformes Species 0.000 claims description 3
- 241001529572 Chaceon affinis Species 0.000 claims description 3
- 229930003756 Vitamin B7 Natural products 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000002086 nanomaterial Substances 0.000 claims description 3
- 239000000941 radioactive substance Substances 0.000 claims description 3
- 235000019515 salmon Nutrition 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000011735 vitamin B7 Substances 0.000 claims description 3
- 235000011912 vitamin B7 Nutrition 0.000 claims description 3
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 239000012188 paraffin wax Substances 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 34
- 229940088598 enzyme Drugs 0.000 description 27
- 239000000047 product Substances 0.000 description 22
- 230000009182 swimming Effects 0.000 description 20
- 206010008342 Cervix carcinoma Diseases 0.000 description 11
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 11
- 201000010881 cervical cancer Diseases 0.000 description 11
- 238000012408 PCR amplification Methods 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 210000003679 cervix uteri Anatomy 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 8
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000013016 damping Methods 0.000 description 7
- 230000007170 pathology Effects 0.000 description 7
- 241000341655 Human papillomavirus type 16 Species 0.000 description 6
- 208000024312 invasive carcinoma Diseases 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 5
- 201000009030 Carcinoma Diseases 0.000 description 5
- 239000006059 cover glass Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 229940079919 digestives enzyme preparation Drugs 0.000 description 4
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 4
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 230000000762 glandular Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000012807 PCR reagent Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 238000009595 pap smear Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 206010059313 Anogenital warts Diseases 0.000 description 2
- 208000009458 Carcinoma in Situ Diseases 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229960002143 fluorescein Drugs 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 201000004933 in situ carcinoma Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- NTGBUUXKGAZMSE-UHFFFAOYSA-N phenyl n-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]carbamate Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(NC(=O)OC=3C=CC=CC=3)=CC=2)CC1 NTGBUUXKGAZMSE-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 208000017572 squamous cell neoplasm Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110415700 CN102409110B (zh) | 2011-12-12 | 2011-12-12 | 一种人***瘤病毒型原位杂交检测试剂盒及其方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110415700 CN102409110B (zh) | 2011-12-12 | 2011-12-12 | 一种人***瘤病毒型原位杂交检测试剂盒及其方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102409110A CN102409110A (zh) | 2012-04-11 |
CN102409110B true CN102409110B (zh) | 2013-08-14 |
Family
ID=45911449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110415700 Active CN102409110B (zh) | 2011-12-12 | 2011-12-12 | 一种人***瘤病毒型原位杂交检测试剂盒及其方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102409110B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103966360B (zh) * | 2014-05-07 | 2016-05-04 | 张家港蓝苏生物工程有限公司 | 一种人***状瘤病毒16/18的检测方法、检测试剂盒和hpv16/18探针 |
CN107523611A (zh) * | 2016-06-22 | 2017-12-29 | 南京大学 | 一种非扩增型核酸杂交捕获体系及其在核酸检测中的应用 |
CN107312838A (zh) * | 2017-06-28 | 2017-11-03 | 广西大学 | 细胞荧光原位杂交方法 |
CN109022616B (zh) * | 2018-07-25 | 2021-11-12 | 广州烨善生物科技有限公司 | 一种检测溶瘤病毒的探针及其应用 |
CN109856383B (zh) * | 2019-03-05 | 2022-04-15 | 肖国林 | 一种用于***辅助诊断的免疫化学染色试剂盒 |
CN112921117B (zh) * | 2019-12-06 | 2022-10-14 | 杭州百殷生物科技有限公司 | 一种用于检测多种人***状瘤病毒分型的试剂盒及操作方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5302519B2 (ja) * | 2007-08-03 | 2013-10-02 | 倉敷紡績株式会社 | ヒトパピローマウイルスを検出するためのプライマーセット及びプローブ |
CN102108423A (zh) * | 2010-12-17 | 2011-06-29 | 武汉百泰基因工程有限公司 | 快速检测16、18型人***瘤病毒的荧光定量pcr试剂盒 |
-
2011
- 2011-12-12 CN CN 201110415700 patent/CN102409110B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102409110A (zh) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102409110B (zh) | 一种人***瘤病毒型原位杂交检测试剂盒及其方法 | |
EP2978863B1 (en) | Differentiation between transient and persistent high risk hpv infection by in situ hybridization | |
CN110628953B (zh) | 一种用于人***瘤病毒分型检测的试剂盒 | |
CN107177699A (zh) | 一种人类***瘤病毒(hpv)分型快速检测方法 | |
CN103725792A (zh) | 人类***瘤病毒(24型)检测(荧光pcr法)试剂盒及其检测方法 | |
WO2012088195A2 (en) | Device and methods for the detection of cervical disease | |
CN104017907B (zh) | 一种hpv高危型荧光pcr检测试剂盒 | |
Munkhdelger et al. | Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix | |
Fan et al. | The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening | |
CN104017906B (zh) | 一种hpv高危型分型荧光pcr检测试剂盒 | |
CN101503741A (zh) | 用于检测高危型人***瘤病毒的试剂盒及其制备和应用 | |
CN105385786A (zh) | 一种人***瘤病毒荧光定量pcr检测试剂盒及其使用方法 | |
CN106048081A (zh) | 一种hpv分型检测引物及其检测方法和应用 | |
CN112575123A (zh) | 引物组合、探针组合以及人***瘤病毒核酸检测试剂盒 | |
Poljak | A review of 20 years of human papillomavirus research in Slovenia | |
CN103966360B (zh) | 一种人***状瘤病毒16/18的检测方法、检测试剂盒和hpv16/18探针 | |
JP2006500952A (ja) | ヒト・パピローマウイルスを定量的且つ定性的に測定するための方法及びキット | |
US7569344B2 (en) | Detection of human papilloma virus in papanicolaou (Pap) smears | |
CA2348413C (en) | Detection of human papilloma virus in papanicolaou (pap) smears | |
CN101824487B (zh) | Pcr结合核酸探针斑点杂交技术检测病料中病毒感染 | |
CN106566894A (zh) | 用于人***瘤病毒高危型感染筛查的引物、探针及其用途 | |
CN103122395A (zh) | 高危型人***瘤病毒hpv16/18检测试剂盒 | |
CN102559932B (zh) | 一种高危人***瘤病毒的pcr检测试剂盒 | |
CN102676690B (zh) | 猪瘟病毒核酸定量检测试剂盒、检测方法、引物及其探针 | |
CN104630384A (zh) | 人***瘤病毒检测的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TRIPLEX INTERNATIONAL BIOSCIENCES CO., LTD. Free format text: FORMER OWNER: TRIPLEX INTERNAT BIOSCIENCES (CHINA) CO., LTD. Effective date: 20150210 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150210 Address after: 350002, No. 7, No. two, No. 7, Jinzhou North Road, Jinshan Industrial Zone, Fujian, Fuzhou, four floors Patentee after: TRIPLEX INTERNATIONAL BIOSCIENCES Co.,Ltd. Address before: 350002, No. 7, No. two, No. 7, Jinzhou North Road, Jinshan Industrial Zone, Fujian, Fuzhou, four floors Patentee before: TRIPLEX INTERNATIONAL BIOSCIENCES (CHINA) Co.,Ltd. |
|
PP01 | Preservation of patent right |
Effective date of registration: 20220411 Granted publication date: 20130814 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20240123 Granted publication date: 20130814 |
|
PD01 | Discharge of preservation of patent |